Strbian D, Durukan A, Tatlisumak T
Department of Neurology, Helsinki University Central Hospital, Finland.
Curr Pharm Des. 2008;14(4):352-8. doi: 10.2174/138161208783497723.
Both intracerebral and subarachnoid hemorrhages are associated with high mortality and most survivors are burdened with severe disability. Currently, there is no approved treatment for intracerebral hemorrhage and surgical evacuation was not proven beneficial. Regarding subarachnoid hemorrhage, existing therapies need substantial improvement. Detailed pathophysiologic mechanisms need to be understood in order to develop novel therapeutic strategies. Hemorrhagic stroke models can help achieve both these goals and answer those questions that cannot be addressed in the clinical setting. There are several animal models of intracerebral and subarachnoid hemorrhage, each mimicking fairly reliably different aspects of the condition studied. The similarities and differences among the existing rodent models, model modifications, and some aspects concerning the choice of relevant model are discussed.
脑内出血和蛛网膜下腔出血均与高死亡率相关,且大多数幸存者都伴有严重残疾。目前,尚无获批的脑内出血治疗方法,手术清除血肿也未被证实有益。对于蛛网膜下腔出血,现有治疗方法需要大幅改进。为了开发新的治疗策略,需要了解详细的病理生理机制。出血性中风模型有助于实现这两个目标,并回答临床环境中无法解决的问题。有几种脑内出血和蛛网膜下腔出血的动物模型,每种模型都能相当可靠地模拟所研究病症的不同方面。本文讨论了现有啮齿动物模型之间的异同、模型改良以及有关选择相关模型的一些方面。